Getinge AB (GNGBY)
21.52
+0.17
(+0.80%)
USD |
OTCM |
May 03, 16:05
Getinge 1 Year Total Returns (Daily): -10.53% for May 2, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 02, 2024 | -10.53% |
| May 01, 2024 | -14.51% |
| April 30, 2024 | -14.65% |
| April 29, 2024 | -12.11% |
| April 26, 2024 | -10.43% |
| April 25, 2024 | -14.47% |
| April 24, 2024 | -15.63% |
| April 23, 2024 | -13.56% |
| April 22, 2024 | -15.68% |
| April 19, 2024 | -20.71% |
| April 18, 2024 | -23.47% |
| April 17, 2024 | -20.28% |
| April 16, 2024 | -19.68% |
| April 15, 2024 | -20.54% |
| April 12, 2024 | -21.63% |
| April 11, 2024 | -18.07% |
| April 10, 2024 | -17.89% |
| April 09, 2024 | -16.37% |
| April 08, 2024 | -15.96% |
| April 05, 2024 | -19.55% |
| April 04, 2024 | -19.57% |
| April 03, 2024 | -19.17% |
| April 02, 2024 | -19.26% |
| April 01, 2024 | -17.29% |
| March 28, 2024 | -11.67% |
| Date | Value |
|---|---|
| March 27, 2024 | -11.31% |
| March 26, 2024 | -13.76% |
| March 25, 2024 | -12.85% |
| March 22, 2024 | -11.86% |
| March 21, 2024 | -9.67% |
| March 20, 2024 | -8.05% |
| March 19, 2024 | -5.94% |
| March 18, 2024 | -6.73% |
| March 15, 2024 | -2.44% |
| March 14, 2024 | -3.57% |
| March 13, 2024 | 0.33% |
| March 12, 2024 | 1.14% |
| March 11, 2024 | 0.84% |
| March 08, 2024 | 1.29% |
| March 07, 2024 | -0.25% |
| March 06, 2024 | -5.08% |
| March 05, 2024 | -5.52% |
| March 04, 2024 | -5.13% |
| March 01, 2024 | -1.84% |
| February 29, 2024 | -6.38% |
| February 28, 2024 | -6.00% |
| February 27, 2024 | -4.73% |
| February 26, 2024 | -1.66% |
| February 23, 2024 | -7.36% |
| February 22, 2024 | -7.92% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-63.60%
Minimum
Sep 23 2022
143.7%
Maximum
Oct 26 2021
26.20%
Average
27.69%
Median
1 Year Total Returns (Daily) Benchmarks
| Abliva AB | -- |
| Karolinska Development AB | 0.00% |
| Calliditas Therapeutics AB | -19.99% |
| Oncopeptides AB | -53.66% |
| Olink Holding AB | 10.53% |